Connection
Daniel Pollyea to Maintenance Chemotherapy
This is a "connection" page, showing publications Daniel Pollyea has written about Maintenance Chemotherapy.
|
|
Connection Strength |
|
|
|
|
|
0.042 |
|
|
|
-
Cortes JE, Douglas Smith B, Wang ES, Merchant A, Oehler VG, Arellano M, DeAngelo DJ, Pollyea DA, Sekeres MA, Robak T, Ma WW, Zeremski M, Naveed Shaik M, Douglas Laird A, O'Connell A, Chan G, Schroeder MA. Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results. Am J Hematol. 2018 11; 93(11):1301-1310.
Score: 0.042